<DOC>
	<DOCNO>NCT00495677</DOCNO>
	<brief_summary>To assess viral load response , safety , tolerability pharmacokinetics multiple oral dos PF 00232798 HIV-positive patient volunteer .</brief_summary>
	<brief_title>A Phase 2 Study Of PF-00232798 In HIV Positive Patients</brief_title>
	<detailed_description />
	<criteria>Asymptomatic HIV1 infect male patient age 18 55 year inclusive . Patients CCR5 tropic virus determine Monogram PhenoSense Entry assay . Patients receive experimental drug within past four month ( prior first dose day study ) previously receive another CCR5 antagonist . Patients evidence decompensated liver disease .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Treatment Experienced</keyword>
	<keyword>Treatment Naive</keyword>
</DOC>